Details of Metabolite
Full List of Protein(s) Regulating This Metabolite | ||||||
---|---|---|---|---|---|---|
Amino acid/auxin permease (AAAP) | ||||||
Sodium-coupled neutral amino acid transporter 9 (SLC38A9) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Truncation of SLC38A9 | |||||
Induced Change | Isoleucine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that truncation of SLC38A9 leads to the increase of isoleucine levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of SLC38A9 | |||||
Induced Change | Isoleucine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of SLC38A9 leads to the decrease of isoleucine levels compared with control group. | |||||
Amino acid/polyamine transporter (AAPT) | ||||||
Integral membrane E16 (SLC7A5) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Overexperisson of SLC7A5 | |||||
Induced Change | Isoleucine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that co-overexperisson of SLC7A5 and SLC7A8 leads to the decrease of isoleucine levels compared with control group. | |||||
L-type amino acid transporter 2 (LAT2) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Overexpression of SLC7A8 | |||||
Induced Change | Isoleucine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of SLC3A2 and SLC7A8 leads to the increase of isoleucine levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Overexperisson of SLC7A8 | |||||
Induced Change | Isoleucine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that co-overexperisson of SLC7A5 and SLC7A8 leads to the decrease of isoleucine levels compared with control group. | |||||
Lymphocyte activation antigen 4F2 (SLC3A2) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Overexpression of SLC3A2 | |||||
Induced Change | Isoleucine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of SLC3A2 and SLC7A8 leads to the increase of isoleucine levels compared with control group. | |||||
GPCR rhodopsin (GPCR-1) | ||||||
Adrenergic receptor beta-3 (ADRB3) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[4] | ||||
Introduced Variation | Agonist (CL-316,243) of Adrb3 | |||||
Induced Change | Isoleucine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that agonist of ADRB3 leads to the increase of isoleucine levels compared with control group. | |||||
Hydrolases (EC 3) | ||||||
Alpha-N-acetylglucosaminidase (NAGLU) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[5] | ||||
Introduced Variation | Knockout of Naglu | |||||
Induced Change | Isoleucine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Lysosomal storage diseases [ICD-11: 5C56] | |||||
Details | It is reported that knockout of Naglu leads to the decrease of isoleucine levels compared with control group. | |||||
Sulfatase sulf-1 (SULF1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[6] | ||||
Introduced Variation | Knockdown (shRNA) of SULF1 | |||||
Induced Change | Isoleucine concentration: decrease (FC = 0.49 / 0.54) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Ovarian cancer [ICD-11: 2C73] | |||||
Details | It is reported that knockdown of SULF1 leads to the decrease of isoleucine levels compared with control group. | |||||
Pore-forming PNC peptide (PNC) | ||||||
Cellular tumor antigen p53 (TP53) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[7] | ||||
Introduced Variation | Knockout of TP53 | |||||
Induced Change | Isoleucine concentration: decrease (Log2 FC=0.84) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colon cancer [ICD-11: 2B90] | |||||
Details | It is reported that knockout of TP53 leads to the decrease of isoleucine levels compared with control group. | |||||
Transcription factor (TF) | ||||||
Myc proto-oncogene protein (MYC) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[8] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Isoleucine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of isoleucine levels compared with control group. | |||||
Transferases (EC 2) | ||||||
Acetylglucosaminyltransferase 5 (MGAT5) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[9] | ||||
Introduced Variation | Knockout of Mgat5 | |||||
Induced Change | Isoleucine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of Mgat5 leads to the increase of isoleucine levels compared with control group. | |||||
Deacetylase sirtuin-5 (SIRT5) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[10] | ||||
Introduced Variation | Knockout of Sirt5 | |||||
Induced Change | Isoleucine concentration: increase (FC = 1.17) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of Sirt5 leads to the increase of isoleucine levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.